Inpatient Care - Czechia | Statista Market Forecast

The Inpatient Care market in Czechia is estimated to achieve a revenue of US$7.09bn in 2024.
It is anticipated that the market will experience a steady annual growth rate (CAGR 2024-2029) of 3.26%, leading to a market volume of US$8.33bn by 2029.
When compared globally, United States is expected to generate the highest revenue, amounting to US$731.40bn in 2024.
In Czechia, there is a growing trend towards incorporating alternative therapies and holistic approaches in inpatient care settings.

Definition:
Inpatient Care refers to medical and surgical services provided to patients who are admitted for overnight stays at hospitals. This market covers a wide range of services, such as diagnostics, medical treatments, and surgical treatments. It also includes facilities, nursing care, and other services that are necessary for the patient's recovery and well-being during their hospital stay. However, inpatient long-term care (LTC) for people with LTC needs is not included. Hospital inpatient care is a crucial component of the healthcare industry and is essential for providing high-quality and comprehensive medical care to patients.

Structure:
Inpatient Care covers Neoplasm Treatments, Treatments of Cardiovascular Diseases, Treatments of Musculoskeletal Diseases, Gastroenterology, Midwifery, and Other Inpatient Care. Other Inpatient Care provides information on additional areas that are not covered by the previously mentioned markets.

Additional information:
Inpatient Care comprises revenues, average revenue per capita, number of hospitals, average revenue per hospital, number of hospital beds, and average revenue per hospital bed. Market values represent revenues paid to hospitals by the respective healthcare payers (including VAT, if applicable). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Inpatient nursing care
Medical goods for inpatient treatments
Inpatient surgical treatments

Day care
Long-term care
Outpatient care
Home-based care

The Inpatient Care market in Czechia has been experiencing significant changes in recent years.

Customer preferences: Customers in Czechia have been increasingly demanding high-quality healthcare services. They are looking for hospitals that offer modern equipment and facilities, as well as highly trained medical staff. Patients in Czechia are also becoming more involved in their healthcare decisions and are seeking greater transparency in the treatment process.

Trends in the market: One of the major trends in the Inpatient Care market in Czechia is the shift towards outpatient care. This is driven by the increasing demand for non-invasive procedures and the need to reduce healthcare costs. As a result, hospitals in Czechia are investing in new technologies and equipment to enable them to provide more outpatient services.Another trend in the market is the growing popularity of private healthcare services. Private hospitals in Czechia are offering high-quality services and are attracting patients who are willing to pay a premium for better care. This has led to increased competition in the market, with public hospitals also striving to improve their services to remain competitive.

Local special circumstances: Czechia has a highly developed healthcare system, with a strong focus on preventive care. The country has a large network of hospitals and clinics, and the government has been investing heavily in healthcare infrastructure in recent years. However, there are still some challenges that need to be addressed, such as the shortage of medical staff in certain areas.

Underlying macroeconomic factors: The Inpatient Care market in Czechia is being influenced by a number of macroeconomic factors. The country has a strong economy and a stable political environment, which has created a favorable environment for investment in healthcare. The aging population in Czechia is also driving demand for healthcare services, particularly in areas such as chronic disease management and long-term care. Additionally, the government has been implementing healthcare reforms aimed at improving the quality and accessibility of healthcare services.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The healthcare landscape in the United States is a complicated one. There are federal health insurance plans for low-income individuals namely Medicaid and CHIP (Children’s health insurance program) and Medicare for seniors and the disabled. Aside from these, people must buy private health insurance or be left uninsured because the U.S. is the only high-income country without universal healthcare coverage. Hospitals in the U.S., therefore, receive payment from multiple payers. Most revenue generated by U.S. hospitals comes from private insurance, self, or other payments. The complexity of this multi-payer system is instrumental to the U.S. having the highest administrative health costs per capita among wealthy nations.